GERN · Geron Corp
$1.47
-0.07 (-4.23%)
At close · Aug 14
Market Cap
$944.44M
Shares
642.47M
Geron Corp Earnings Call Transcripts
Every quarterly earnings call for Geron Corp (GERN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲172.5%
$297,000
−$41.05M
'22 Q3
22-11-03
▼90.1%
$103,000
−$42.63M
'22 Q4
23-03-16
▼82.9%
$21,000
−$38.12M
'23 Q1
23-04-20
▼60.3%
$29,000
−$49.23M
'23 Q2
23-08-03
▼44.8%
$164,000
−$44.80M
'23 Q3
23-11-02
▼77.7%
$23,000
−$51.97M
'23 Q4
24-01-08
▲1347.6%
$304,000
−$55.39M
'24 Q1
24-05-02
▲2941.4%
$882,000
−$67.38M
'24 Q2
24-08-08
▲17138.4%
$28.27M
−$26.45M
'24 Q3
24-11-07
▲12927.3%
$39.60M
−$19.84M
'25 Q1
25-05-07
▲5459.6%
$49.04M
−$16.38M
'25 Q2
25-08-06
▲67.1%
$47.23M
−$18.43M
'25 Q3
25-11-05
▲30.9%
$51.84M
−$3.64M
'26 Q1
26-05-06
LATEST
▲17.2%
$57.48M
−$16.68M
'26 Q2
26-08-05
Earnings call
FY26 · Q2
2026-08-05
Q2 2026 Geron Earnings Conference Call
Confident tone
Ritello commercial performance and demand growth
Real-world evidence and medical engagement
Phase 3 IMpactMS trial in myelofibrosis
Revenue
$57.48M
▲ 17.2% YoY Diluted EPS
$-0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Geron Corp Q1 FY2026 Earnings Call
Positive tone
RYTELO U.S. commercial growth
European commercial and pricing strategy
Medical affairs / hematology engagement
Revenue
$51.84M
▲ 30.9% YoY Diluted EPS
$-0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-13
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-10
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-25
Geron Corp Q4 FY2025 Earnings Call
Confident tone
Rytelo commercial growth and second-line MDS opportunity
3D surround sound and field force execution
2026 financial guidance and path to profitability
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Geron Corp Q3 FY2025 Earnings Call
Positive tone
RYTELO commercial performance and growth
Healthcare provider awareness and education
Commercial execution and strategy reset
Revenue
$47.23M
▲ 67.1% YoY Diluted EPS
$-0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Geron Corp Q2 FY2025 Earnings Call
Positive tone
RYTELO U.S. commercial performance
HCP awareness and earlier-line adoption
EU launch and partnering strategy
Revenue
$49.04M
▲ 5459.6% YoY Diluted EPS
$-0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Geron Corp Q1 FY2025 Earnings Call
Positive tone
RYTELO U.S. commercial launch
IMPACT MS Phase 3 in myelofibrosis
Commercial strategy enhancements
Revenue
$39.60M
▲ 12927.3% YoY Diluted EPS
$-0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Geron Corp Q4 FY2024 Earnings Call
Positive tone
RYTELO commercial launch and revenue trends
Myelofibrosis IMpactMF Phase 3 trial
Duration of treatment
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Geron Corp Q3 FY2024 Earnings Call
Confident tone
RYTELO U.S. Commercial Launch Performance
Lower-Risk MDS Market Opportunity and Demand
Financing Transactions and Capital Position
Revenue
$28.27M
▲ 17138.4% YoY Diluted EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Geron Corp Q2 FY2024 Earnings Call
Confident tone
RYTELO commercial launch
NCCN Guidelines inclusion
Lower-risk MDS market opportunity
Revenue
$882,000
▲ 2941.4% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Geron Corp Q1 FY2024 Earnings Call
Confident tone
U.S. Launch of Imetelstat in Lower-Risk MDS
Market Differentiation and Unmet Need
FDA / Regulatory Progress
Revenue
$304,000
▲ 1347.6% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Geron Corp Q4 FY2023 Earnings Call
Confident tone
FDA regulatory review and ODAC
IMerge Phase 3 clinical data in lower-risk MDS
IMpactMF Phase 3 in myelofibrosis
Revenue
$23,000*
▼ 77.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Geron Corp Q3 FY2023 Earnings Call
Revenue
$164,000
▼ 44.8% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Geron Corp Q2 FY2023 Earnings Call
Revenue
$29,000
▼ 60.3% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-20
Geron Corp Q1 FY2023 Earnings Call
Revenue
$21,000
▼ 82.9% YoY Diluted EPS
$-0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Geron Corp Q4 FY2022 Earnings Call
Revenue
$103,000*
▼ 90.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Geron Corp Q3 FY2022 Earnings Call
Revenue
$297,000
▲ 172.5% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Geron Corp Q2 FY2022 Earnings Call
Revenue
$73,000
▼ 31.8% YoY Diluted EPS
$-0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-13
Geron Corp Q1 FY2022 Earnings Call
Revenue
$123,000
▼ 10.2% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Geron Corp Q4 FY2021 Earnings Call
Revenue
$1.04M*
▲ 1980% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Geron Corp Q3 FY2021 Earnings Call
Revenue
$109,000
▲ 0.9% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Geron Corp Q2 FY2021 Earnings Call
Revenue
$107,000
▲ 148.8% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Geron Corp Q1 FY2021 Earnings Call
Revenue
$137,000
▲ 163.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
Geron Corp Q4 FY2020 Earnings Call
Revenue
$50,000*
▼ 70.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Geron Corp Q3 FY2020 Earnings Call
Revenue
$108,000
▼ 17.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Geron Corp Q2 FY2020 Earnings Call
Revenue
$43,000
▼ 57.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-28
Geron Corp Q1 FY2020 Earnings Call
Revenue
$52,000
▼ 8.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–29 of 29 earnings calls
Key facts
CIK
886744
CUSIP
374163103
13F (30d)
250 filings
247 filers
Visit website
Investor relations